@article{3d1c93c3c8da455282897bd12a005dde,
title = "Editorial to “Molecular engineering of biomaterials programmed to operate in living systems”",
author = "Afonin, \{Kirill A.\} and Dokholyan, \{Nikolay V.\}",
note = "Funding Information: Mark Jensen of the Frederick National Laboratory for Cancer Research and his colleagues open the issue by discussing trends and patterns in cancer nanotechnology research compiled based on the data available through the two unique resources established and funded by the National Cancer Institute (NCI) to support the extramural research community – the Nanotechnology Characterization Laboratory and the caNanoLab. The trends cover nanoparticle physicochemical properties in connection with the biocompatibility (toxicity, immunotoxicity, and biodistribution) of cancer nanotechnology formulations, protocols, and methods for nanoparticle characterization; most importantly, the authors discuss the bioinformatics resources available to the cancer nanotechnology research community through these NCI-funded programs [1] . Funding Information: The research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R35GM139587 (to K.A.A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also acknowledge support from the National Institutes of Health 1R35 GM134864, 1RF1 AG071675 and the Passan Foundation (to N.V.D.).",
year = "2023",
month = feb,
doi = "10.1016/j.addr.2022.114669",
language = "English (US)",
volume = "193",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier B.V.",
}